Restoring Provider Confidence In FDA-Approved Drugs
The Kaiser Permanente Institute for Health Policy's experts Samantha Dupont, Krysten Joyce and Murray Ross join Kaiser Permanente's Senior Vice…
Evolving nature of evidence required by FDA to approve new drugs
This brief, based on systematic reviews conducted in collaboration with the Program on Therapeutics, And Law (PORTAL), provides background on…
Health care workforce needs and Kaiser Permanente’s approach
download as a PDF The challenge Health care workforce needs To meet the health care needs of the future, the…
